TY - JOUR
T1 - Diagnosing active inflammation in the SAPHO syndrome using 18FDG-PET/CT in suspected metastatic vertebral bone tumors
AU - Inoue, Kentaro
AU - Yamaguchi, Tatsuo
AU - Ozawa, Hiroshi
AU - Okada, Ken
AU - Taki, Yasuyuki
AU - Goto, Ryoi
AU - Kinomura, Shigeo
AU - Kaneta, Tomohiro
AU - Fukuda, Hiroshi
N1 - Funding Information:
Acknowledgment This work was supported by a grant-in-aid for cancer research (17-12) from the Ministry of Health, Labour and Welfare, Japan.
PY - 2007/10
Y1 - 2007/10
N2 - The vertebral spine is frequently affected by the SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome. We report the collective imaging findings of hybrid F-18 fluorodeoxyglucose-positron emission tomography/computed tomography (18FDG-PET/CT), as well as bone scans and magnetic resonance imaging, in a patient who had suspected metastatic vertebral bone tumors. 18FDG-PET/CT can be utilized to exclude metastatic vertebral tumors, as well as identifying stable lesions, by demonstrating active inflammatory lesions with accurate anatomic localization through the convergence of the functional information from 18FDG uptake with the anatomic information of CT.
AB - The vertebral spine is frequently affected by the SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome. We report the collective imaging findings of hybrid F-18 fluorodeoxyglucose-positron emission tomography/computed tomography (18FDG-PET/CT), as well as bone scans and magnetic resonance imaging, in a patient who had suspected metastatic vertebral bone tumors. 18FDG-PET/CT can be utilized to exclude metastatic vertebral tumors, as well as identifying stable lesions, by demonstrating active inflammatory lesions with accurate anatomic localization through the convergence of the functional information from 18FDG uptake with the anatomic information of CT.
KW - F-18 fluorodeoxyglucose
KW - PET/CT
KW - SAPHO syndrome
UR - http://www.scopus.com/inward/record.url?scp=35448942752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35448942752&partnerID=8YFLogxK
U2 - 10.1007/s12149-007-0051-x
DO - 10.1007/s12149-007-0051-x
M3 - Article
C2 - 17952557
AN - SCOPUS:35448942752
SN - 0914-7187
VL - 21
SP - 477
EP - 480
JO - Annals of Nuclear Medicine
JF - Annals of Nuclear Medicine
IS - 8
ER -